C-reactive protein and the vascular endothelium: Implications for plaque instability

Journal of the American College of Cardiology

Volumn 47, Issue 7, 2006, Pages 1379-1381

  Jialal, Ishwarlal ^a   Devaraj, Sridevi ^a   Singh, Uma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD32 ANTIGEN; CD64 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN 2; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1;

CELL ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; MACROPHAGE; NOTE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 33645395282     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.01.034     Document Type: Editorial

References (24)

1. J.T. Willerson, P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 Suppl 1 2004 II2 II10
2. T.A. Pearson, G.A. Mensah, Y. Hong CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to clinical and public health practice: overview Circulation 110 2004 e543 e544
3. S.M. Grundy, J.I. Cleeman, C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
4. K. Yasojima, C. Schwab, E.G. McGeer, P.L. McGeer Generation of C-reactive protein and complement components in atherosclerotic plaques Am J Pathol 158 2001 1039 1051
5. S.K. Venugopal, S. Devaraj, I. Jialal Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells potential for paracrine/autocrine effects Am J Pathol 166 2005 1265 1271
6. I. Jialal, S. Devaraj, S.K. Venugopal C-reactive protein risk marker or mediator in atherothrombosis? Hypertension 44 2004 6 11
7. I. Montero, J. Orbe, N. Varo C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells implications for clinical and subclinical atherosclerosis J Am Coll Cardiol 47 2006 1369 1378
8. T.N. Williams, C.X. Zhang, B.A. Game, L. He, Y. Huang C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway an implication of CRP involvement in plaque destabilization Arterioscler Thromb Vasc Biol 24 2004 61 66
9. S. Devaraj, T.W. DuClos, I. Jialal Binding and internalization of C-reactive protein by Fc gamma receptors on human aortic endothelial cells mediates biological effects Arterioscler Thromb Vasc Biol 25 2005 1359 1363
10. R. Lin, J. Liu, W. Gan, G. Yang C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells Biol Pharm Bull 27 2004 1537 1543
11. V. Pasceri, J.T. Willerson, E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
12. U. Singh, S. Devaraj, I. Jialal C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells evidence that C-reactive protein is a procoagulant Arterioscler Thromb Vasc Biol 25 2005 2216 2221
13. T. Nakakuki, M. Ito, H. Iwasaki Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells Arterioscler Thromb Vasc Biol 25 2005 2088 2093
14. H.D. Danenberg, A.J. Szalai, R.V. Swaminathan Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice Circulation 108 2003 512 515
15. J.A. deLemos, M.A. Blazing, S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes phase Z of the A to Z trial JAMA 292 2004 1307 1316
16. S.M. Macin, E.R. Perna, E.F. Farias Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome results of a randomized, double-blind, placebo-controlled study Am Heart J 149 2005 451 457
17. T. Mezaki, T. Matsubara, T. Hori Plasma levels of soluble thrombomodulin, C-reactive protein, and serum amyloid A protein in the atherosclerotic coronary circulation Jpn Heart J 44 2003 601 612
18. T. Inoue, T. Kato, T. Uchida Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting J Am Coll Cardiol 46 2005 239 245
19. T. Ishikawa, T. Imamura, K. Hatakeyama Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation Am J Cardiol 93 2004 611 614
20. M. Griselli, J. Herbert, W.L. Hutchinson C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 190 1999 1733 1740
21. R. Gill, J.A. Kemp, C. Sabin, M.B. Pepys Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats J Cereb Blood Flow Metab 24 2004 1214 1218
22. C.H. Wang, S.H. Li, R.D. Weisel C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 2003 1783 1790
23. M.B. Pepys CRP or not CRP? That is the question Arterioscler Thromb Vasc Biol 25 2005 1091 1094
24. K.K. Ray, C.P. Cannon, R. Cairns PROVE IT-TIMI 22 Investigators Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial J Am Coll Cardiol 46 2005 1417 1424